
|
Impaired
replication of protease inhibitor-resistant HIV-1 in human thymus
[Stoddart
CA et al. Nature Medicine 2001; 7: 712]:Prior studies have
shown that some patients with virologic failure have persistent
production of new CD4 cells, and a prior study showed that PI-resistant
strains of HIV retain virulence for peripheral CD4 cells. This led
to the hypothesis that these resistant strains have reduced replication
capacity in the thymus. This report addresses the question by comparing
the replication of wild-type versus PI-resistant HIV strains in
peripheral blood mononuclear cells, thymic cultures, and human thymus
implants in SCID-hu Thy/Liv mice. In thi study both types of strains
replicated well in PBMC, but the PI-resistant strains had a marked
reduction in replicative capacity in thymocytes. The authors conclude
that this reduced replicative capacity in HIV in the thymus facilitates
preservation of the CD4 cell counts in some patients who fail PI-based
regimens.
Comment: This is a potentially important observation in terms
of strategies for managing HIV. The attention has previously been
on the paradoxical benefit of regimens with PIs which now seems
explained. The application to NNRTI-based regimens is unknown.
posted
6/14/2001
|

|